Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Oct;146(4):e20193318.
doi: 10.1542/peds.2019-3318. Epub 2020 Sep 17.

Early Hypoxic Respiratory Failure in Extreme Prematurity: Mortality and Neurodevelopmental Outcomes

Praveen Chandrasekharan  1 , Satyan Lakshminrusimha  2 , Dhuly Chowdhury  3 , Krisa Van Meurs  4 , Martin Keszler  5 , Haresh Kirpalani  6 , Abhik Das  3 , Michele C Walsh  7 , Elisabeth C McGowan  5 , Rosemary D Higgins  8   9 ; NRN STEERING COMMITTEE
Affiliations
Multicenter Study

Early Hypoxic Respiratory Failure in Extreme Prematurity: Mortality and Neurodevelopmental Outcomes

Praveen Chandrasekharan et al. Pediatrics. 2020 Oct.

Abstract

Objectives: To evaluate the survival and neurodevelopmental impairment (NDI) in extremely low birth weight (ELBW) infants at 18 to 26 months with early hypoxemic respiratory failure (HRF). We also assessed whether African American infants with early HRF had improved outcomes after exposure to inhaled nitric oxide (iNO).

Methods: ELBW infants ≤1000 g and gestational age ≤26 weeks with maximal oxygen ≥60% on either day 1 or day 3 were labeled as "early HRF" and born between 2007 and 2015 in the Neonatal Research Network were included. Using a propensity score regression model, we analyzed outcomes and effects of exposure to iNO overall and separately by race.

Results: Among 7639 ELBW infants born ≤26 weeks, 22.7% had early HRF. Early HRF was associated with a mortality of 51.3%. The incidence of moderate-severe NDI among survivors was 41.2% at 18 to 26 months. Mortality among infants treated with iNO was 59.4%. Female sex (adjusted odds ratio [aOR]: 2.4, 95% confidence interval [CI]: 1.8-3.3), birth weight ≥720 g (aOR: 2.3, 95% CI: 1.7-3.1) and complete course of antenatal steroids (aOR: 1.6, 95% CI: 1.1-2.2) were associated with intact survival. African American infants had a similar incidence of early HRF (21.7% vs 23.3%) but lower exposure to iNO (16.4% vs 21.6%). Among infants with HRF exposed to iNO, intact survival (no death or NDI) was not significantly different between African American and other races (aOR: 1.5, 95% CI: 0.6-3.6).

Conclusions: Early HRF in infants ≤26 weeks' gestation is associated with high mortality and NDI at 18 to 26 months. Use of iNO did not decrease mortality or NDI. Outcomes following iNO exposure were not different in African American infants.

Trial registration: ClinicalTrials.gov NCT00063063.

PubMed Disclaimer

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
The flowchart of ELBW infants ≤26 weeks’ gestation with early HRF.
FIGURE 2
FIGURE 2
The Kaplan–Meier plot shows the probability of survival (y-axis) by days (x-axis), between infants with HRF (interrupted line) versus infants without HRF (continuous line).
FIGURE 3
FIGURE 3
The flowchart of ELBW infants ≤26 weeks’ gestation with early HRF whose mother self-identified as African American.
See this image and copyright information in PMC

References

    1. Polin RA, Carlo WA; Committee on Fetus and Newborn; American Academy of Pediatrics . Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014;133(1):156–163 - PubMed
    1. Van Meurs KP, Wright LL, Ehrenkranz RA, et al. .; Preemie Inhaled Nitric Oxide Study . Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005;353(1):13–22 - PubMed
    1. Giesinger RE, More K, Odame J, Jain A, Jankov RP, McNamara PJ. Controversies in the identification and management of acute pulmonary hypertension in preterm neonates. Pediatr Res. 2017;82(6):901–914 - PubMed
    1. Cole FS, Alleyne C, Barks JD, et al. . NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics. 2011;127(2):363–369 - PubMed
    1. Kumar P; Committee on Fetus and Newborn; American Academy of Pediatrics . Use of inhaled nitric oxide in preterm infants. Pediatrics. 2014;133(1):164–170 - PubMed

Publication types

MeSH terms

Associated data